e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ASE Technology Holding Co., Ltd. American Depositary Shares (each representing
(NY:
ASX
)
10.01
+0.51 (+5.37%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
OTC Markets Group Welcomes Talga Group Ltd. to OTCQX
Today 7:00 EDT
From
OTC Markets
Via
GlobeNewswire
Earnings Scheduled For July 31, 2025
July 31, 2025
Via
Benzinga
A Peek at ASE Tech Holding Co's Future Earnings
July 30, 2025
Via
Benzinga
Appendix 4C – Q4 FY25 Quarterly Cash Flow Report
July 30, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Earnings Scheduled For April 30, 2025
April 30, 2025
Via
Benzinga
P/E Ratio Insights for ASE Technology Holding Co
April 29, 2025
Via
Benzinga
Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy
July 28, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study
July 24, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
OTC Markets Group Welcomes Andean Silver Ltd to OTCQX
July 18, 2025
From
OTC Markets
Via
GlobeNewswire
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
July 11, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
June 23, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Life360 Enhances Ad Platform With Launch of Place Ads and Uplift, Redefining Real-World Targeting and Measurement
June 12, 2025
Company introduces breakthrough ad tools that deliver brand messages based on real-world behavior and prove in-store impact with deterministic measurement
From
Life360, Inc.
Via
GlobeNewswire
Life360 Announces Closing of Upsized $320 Million Offering of 0.00% Convertible Senior Notes
June 05, 2025
From
Life360, Inc.
Via
GlobeNewswire
Life360 Announces Pricing of Upsized Convertible Senior Notes Offering
June 03, 2025
From
Life360, Inc.
Via
GlobeNewswire
Life360 Proposes Convertible Senior Notes Offering
June 02, 2025
From
Life360, Inc.
Via
GlobeNewswire
ASE Announces FOCoS-Bridge With TSV; Latest Package Technology Reduces Power Loss by 3x for Next-Generation AI and HPC Applications
May 28, 2025
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
5 Undervalued Stocks To Buy On China Tariff Cuts
May 21, 2025
Via
Benzinga
Life360 Reports Record Q1 2025 Results
May 12, 2025
From
Life360, Inc.
Via
GlobeNewswire
Alterity Therapeutics Prominently Featured at the International MSA Congress
May 12, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
May 07, 2025
ATH434 Phase 2 Data to be Presented at Opening Plenary Session
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
May 05, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
April 30, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
April 28, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Technology Holding Co Honors Outstanding Suppliers of 2024
April 11, 2025
From
ASE Technology Holding Co., Ltd.
Via
Business Wire
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
April 10, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
April 03, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Demonstrates CPO that Improves Energy Efficiency for AI applications
April 01, 2025
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy
March 27, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Oil & Gas Virtual Investor Conference Agenda Announced for March 27th
March 25, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life360 Adds a Touch of Kawaii With Tile X Hello Kitty®, a Limited-Edition Collection in Partnership With Sanrio
March 20, 2025
Hello Kitty® Adds Her Supercute Charm to a Specially Designed Lineup of Bluetooth Trackers, Tile Mate and Tile Slim, Available Starting March 20
From
Life360, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
wpDiscuz
Insert
